Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jun '25 Jun 16, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	39,508	55,558	36,109	28,508	59,346	-	Upgrade
Market Cap Growth	11.98%	53.86%	26.67%	-51.96%	-	-	Upgrade
Enterprise Value	31,765	48,535	30,432	20,657	47,493	-	Upgrade
PS Ratio	32.33	45.32	47.92	36.68	284.42	-	Upgrade
PB Ratio	2.07	2.58	4.61	3.01	5.33	-	Upgrade
P/TBV Ratio	4.39	4.85	5.70	3.02	5.35	-	Upgrade
EV/Sales Ratio	27.96	39.59	40.38	26.58	227.62	-	Upgrade
Debt / Equity Ratio	0.10	0.11	0.11	0.11	0.00	0.05	Upgrade
Asset Turnover	0.06	0.06	0.07	0.06	0.02	0.02	Upgrade
Quick Ratio	3.85	3.43	4.24	5.51	11.27	11.36	Upgrade
Current Ratio	4.11	3.81	4.70	5.68	11.46	11.54	Upgrade
Return on Equity (ROE)	-86.10%	-61.90%	-69.12%	-46.56%	-47.51%	-54.57%	Upgrade
Return on Assets (ROA)	-38.51%	-28.48%	-32.29%	-23.42%	-25.14%	-26.44%	Upgrade
Return on Capital (ROIC)	-48.52%	-36.13%	-41.64%	-28.43%	-28.62%	-30.76%	Upgrade
Earnings Yield	-29.74%	-17.39%	-15.36%	-16.39%	-6.44%	-	Upgrade
FCF Yield	-20.57%	-13.98%	-14.03%	-8.25%	-6.85%	-	Upgrade
Buyback Yield / Dilution	-44.27%	-31.92%	-18.41%	-40.04%	-475.48%	-0.98%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.